High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2)

被引:13
|
作者
Battista, S
Fedele, M
Hoyos, JM
Pentimalli, F
Pierantoni, GM
Visone, R
De Martino, I
Croce, CM
Fusco, A
机构
[1] Univ Naples Federico II, Fac Med & Chirurg Napoli, Dipartimento Biol & Patol Cellulare & Mol, CNR,Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[3] CEINGE, NOGEC, I-80145 Naples, Italy
关键词
electrophoretic mobility-shift assay (EMSA); embryonic stem cell; high-mobility-group A1 (HMGA1); lymphopoiesis; MEF; recombination activating gene 2 (RAG2);
D O I
10.1042/BJ20041607
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HMGA1 (high-mobility-group A1) proteins are architectural transcription factors that are found overexpressed in embryogenesis and malignant tumours. We have shown previously that they have a role in lymphopoiesis, since the loss of HMGA1 expression leads to an impairment of T-cell development and to an increase in B-cell population. Since RAGs (recombination activating genes) are key regulators of lymphoid differentiation, in the present study we investigate whether RAG2 expression is dependent on HMGA1 activity. We show that RAG2 gene expression is up-regulated in Hmgal-/- ES (embryonic stem) cells and EBs (embryoid bodies) as well as in yolk sacs and fibroblasts from Hmgal-/- mice, suggesting that HMGA1 proteins control RAG2 gene expression both in vitro and in vivo. We show that the effect of HMGA1 on RAG2 expression is direct, identify the responsible region in the RAG2 promoter and demonstrate binding to the promoter in vivo using chromatin immunoprecipitation. Since RAG2 is necessary for lymphoid cell development, our results suggest a novel mechanism by which HMGA1 might regulate lymphoid differentiation.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [1] High-mobility-group chromosomal proteins, HMGA1 as potential tumour markers
    Rajeswari, MR
    Jain, A
    CURRENT SCIENCE, 2002, 82 (07): : 838 - 844
  • [2] High Mobility Group A1 (HMGA1) Proteins in Invasive Lobular Carcinoma
    Asch-Kendrick, R. J.
    Meeker, A.
    Argani, P.
    Resar, L.
    Cinino-Mathews, A.
    MODERN PATHOLOGY, 2014, 27 : 36A - 36A
  • [3] High Mobility Group A1 (HMGA1) Proteins in Invasive Lobular Carcinoma
    Asch-Kendrick, R. J.
    Meeker, A.
    Argani, P.
    Resar, L.
    Cimino-Mathews, A.
    LABORATORY INVESTIGATION, 2014, 94 : 36A - 36A
  • [4] Mapping and Quantitation of the Interaction between the Recombination Activating Gene Proteins RAG1 and RAG2
    Zhang, Yu-Hang
    Shetty, Keerthi
    Surleac, Marius D.
    Petrescu, Andrei J.
    Schatz, David G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (19) : 11802 - 11817
  • [5] Characterization and expression of the recombination activating genes (rag1 and rag2) of zebrafish
    Willett, CE
    Cherry, JJ
    Steiner, LA
    IMMUNOGENETICS, 1997, 45 (06) : 394 - 404
  • [6] Characterization and expression of the recombination activating genes (rag1 and rag2) of zebrafish
    Catherine E. Willett
    Jason J. Cherry
    Lisa A. Steiner
    Immunogenetics, 1997, 45 : 394 - 404
  • [7] Recombination-activating gene 1 and 2 (RAG1 and RAG2) in flounder (Paralichthys olivaceus)
    Wang, Xianlei
    Tan, Xungang
    Zhang, Pei-Jun
    Zhang, Yuqing
    Xu, Peng
    JOURNAL OF BIOSCIENCES, 2014, 39 (05) : 849 - 858
  • [8] Recombination-activating gene 1 and 2 (RAG1 and RAG2) in flounder (Paralichthys olivaceus)
    Xianlei Wang
    Xungang Tan
    Pei-Jun Zhang
    Yuqing Zhang
    Peng Xu
    Journal of Biosciences, 2014, 39 : 849 - 858
  • [9] Elevated levels of high-mobility-group chromosomal proteins, HMGA1, in murine skin carcinoma
    Rajeswari, MR
    Singh, D
    Jain, A
    Ray, R
    CANCER LETTERS, 2001, 173 (01) : 93 - 99
  • [10] The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
    Sumter, T. F.
    Xian, L.
    Huso, T.
    Koo, M.
    Chang, Y. -T.
    Almasri, T. N.
    Chia, L.
    Inglis, C.
    Reid, D.
    Resar, L. M. S.
    CURRENT MOLECULAR MEDICINE, 2016, 16 (04) : 353 - 393